Assessment of three Resistance-Nodulation-Cell Division drug efflux transporters of Burkholderia cenocepacia in intrinsic antibiotic resistance

BMC Microbiology

Volumn 9, Issue , 2009, Pages

  Buroni, Silvia ^a   Pasca, Maria R ^a   Flannagan, Ronald S ^b   Bazzini, Silvia ^a   Milano, Anna ^a   Bertani, Iris ^c   Venturi, Vittorio ^c   Valvano, Miguel A ^b   Riccardi, Giovanna ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; CARRIER PROTEIN; CHLORAMPHENICOL; CIPROFLOXACIN; ETHIDIUM BROMIDE; GENTAMICIN; LEVOFLOXACIN; N ACYLHOMOSERINE LACTONE; NALIDIXIC ACID; NORFLOXACIN; PERIPLASMIC PROTEIN; PROTEIN RND 1; PROTEIN RND 3; PROTEIN RND 4; SPARFLOXACIN; TOBRAMYCIN; UNCLASSIFIED DRUG; BACTERIAL DNA; GAMMA BUTYROLACTONE DERIVATIVE; OFLOXACIN; OUTER MEMBRANE PROTEIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BURKHOLDERIA CENOCEPACIA; CELL DIVISION; DRUG TRANSPORT; GENE DELETION; NODULATION; NONHUMAN; OPERON; QUORUM SENSING; BURKHOLDERIA CEPACIA; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MICROBIOLOGICAL EXAMINATION; MULTIDRUG RESISTANCE; MUTAGENESIS;

BACTERIA (MICROORGANISMS); BURKHOLDERIA CENOCEPACIA; NEGIBACTERIA;

ACYL-BUTYROLACTONES; BACTERIAL OUTER MEMBRANE PROTEINS; BURKHOLDERIA CEPACIA; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; GENES, BACTERIAL; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; MUTAGENESIS; OFLOXACIN; OPERON; QUORUM SENSING;

EID: 70349779663     PISSN: 14712180     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-9-200     Document Type: Article

References (44)

1. Taxonomy and identification of the Burkholderia cepacia complex. T Coenye P Vandamme JR Govan JJ LiPuma, J Clin Microbiol 2001 39 10 3427 3436 10.1128/JCM.39.10.3427-3436.2001 11574551
2. Taxonomy and pathogenesis of the Burkholderia cepacia complex. E Mahenthiralingam P Vandamme, Chron Respir Dis 2005 2 4 209 217 10.1191/1479972305cd053ra 16541604 (Pubitemid 41527263)
3. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. A Isles I Maclusky M Corey R Gold C Prober P Fleming H Levison, J Pediatr 1984 104 2 206 210 10.1016/S0022-3476(84)80993-2 6420530
4. Evolving epidemiology of Pseudomonas aeruginosa and the Burkholderia cepacia complex in cystic fibrosis lung infection. JR Govan AR Brown AM Jones, Future Microbiol 2007 2 153 164 10.2217/17460913.2.2.153 17661652
5. Multidrug-resistant organisms in cystic fibrosis: management and infection-control issues. V Waters F Ratjen, Expert Rev Anti Infect Ther 2006 4 5 807 819 10.1586/14787210.4.5.807 17140357
6. Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission. L Saiman J Siegel Cystic Fibrosis Foundation, Infect Control Hosp Epidemiol 2003 24 Suppl 5 6 52 10.1086/503485 12789902
7. Outer membrane permeability in Pseudomonas cepacia : diminished porin content in a beta-lactam-resistant mutant and in resistant cystic fibrosis isolates. SC Aronoff, Antimicrob Agents Chemother 1988 32 11 1636 1639 2855296
8. Involvement of outer membrane of Pseudomonas cepacia in aminoglycoside and polymyxin resistance. RA Moore RE Hancock, Antimicrob Agents Chemother 1986 30 6 923 926 3028253
9. Role of porins in intrinsic antibiotic resistance of Pseudomonas cepacia. TR Parr Jr RA Moore LV Moore RE Hancock, Antimicrob Agents Chemother 1987 31 1 121 123 3032087
10. Characterization of the penA and penR genes of Burkholderia cepacia 249 which encode the chromosomal class A penicillinase and its LysR-type transcriptional regulator. S Trépanier A Prince A Huletsky, Antimicrob Agents Chemother 1997 41 11 2399 2405 9371340
11. Isolation and characterization of dihydrofolate reductase from trimethoprim-susceptible and trimethoprim-resistant Pseudomonas cepacia. JL Burns DM Lien LA Hedin, Antimicrob Agents Chemother 1989 33 8 1247 1251 2802552
12. Nucleotide sequence analysis of a gene from Burkholderia (Pseudomonas) cepacia encoding an outer membrane lipoprotein involved in multiple antibiotic resistance. JL Burns CD Wadsworth JJ Barry CP Goodall, Antimicrob Agents Chemother 1996 40 2 307 313 8834871
13. Cloning and characterization of the Burkholderia vietnamiensis norM gene encoding a multi-drug efflux protein. CC Fehlner-Gardiner MA Valvano, FEMS Microbiol Lett 2002 215 2 279 283 10.1111/j.1574-6968.2002.tb11403.x 12399047
14. Identification of an immunodominant drug efflux pump in Burkholderia cepacia. SM Wigfield GP Rigg M Kavari AK Webb RC Matthews JP Burnie, J Antimicrob Chemother 2002 49 4 619 624 10.1093/jac/49.4.619 11909835
15. Multidrug efflux in Pseudomonas aeruginosa: components, mechanisms and clinical significance. K Poole R Srikumar, Curr Top Med Chem 2001 1 1 59 71 10.2174/1568026013395605 11895293
16. Efflux-mediated multiresistance in Gram-negative bacteria. K Poole, Clin Microbiol Infect 2004 10 1 12 26 10.1111/j.1469-0691.2004.00763.x 14706082
17. Crystal structure of the membrane fusion protein, MexA, of the multidrug transporter in Pseudomonas aeruginosa. H Akama T Matsuura S Kashiwagi H Yoneyama S Narita T Tsukihara A Nakagawa T Nakae, J Biol Chem 2004 279 25 25939 25942 10.1074/jbc.C400164200 15117957
18. Crystal structure of the drug discharge outer membrane protein, OprM, of Pseudomonas aeruginosa: dual modes of membrane anchoring and occluded cavity end. H Akama M Kanemaki M Yoshimura T Tsukihara T Kashiwagi H Yoneyama S Narita A Nakagawa T Nakae, J Biol Chem 2004 279 51 52816 52819 10.1074/jbc.C400445200 15507433
19. Structure of the periplasmic component of a bacterial drug efflux pump. MK Higgins E Bokma E Koronakis C Hughes V Koronakis, Proc Natl Acad Sci USA 2004 101 27 9994 9999 10.1073/pnas.0400375101 15226509
20. Crystal structure of the bacterial membrane protein TolC central to multidrug efflux and protein export. V Koronakis A Sharff E Koronakis B Luisi C Hughes, Nature 2000 405 6789 914 919 10.1038/35016007 10879525
21. Crystal structure of bacterial multidrug efflux transporter AcrB. S Murakami R Nakashima E Yamashita A Yamaguchi, Nature 2002 419 6907 587 593 10.1038/nature01050 12374972
22. BpeAB-OprB, a multidrug efflux pump in Burkholderia pseudomallei. YY Chan TM Tan YM Ong KL Chua, Antimicrob Agents Chemother 2004 48 4 1128 1135 10.1128/AAC.48.4.1128-1135.2004 15047512
23. Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei. RA Moore D DeShazer S Reckseidler A Weissman DE Woods, Antimicrob Agents Chemother 1999 43 3 465 470 10049252
24. Interplay between efflux pumps may provide either additive or multiplicative effects on drug resistance. A Lee W Mao MS Warren A Mistry K Hoshino R Okumura H Ishida O Lomovskaya, J Bacteriol 2000 182 11 3142 3150 10.1128/JB.182.11.3142-3150.2000 10809693
25. Control of quorum sensing by a Burkholderia pseudomallei multidrug efflux pump. YY Chan HS Bian TM Tan ME Mattmann GD Geske J Igarashi T Hatano H Suga HE Blackwell KL Chua, J Bacteriol 2007 189 11 4320 4324 10.1128/JB.00003-07 17384185
26. Inhibitors of efflux pumps in Gram-negative bacteria. JM Pagès M Masi J Barbe, Trends Mol Med 2005 11 8 382 389 10.1016/j.molmed.2005.06.006 15996519
27. Salicylate induces an antibiotic efflux pump in Burkholderia cepacia complex genomovar III (B. cenocepacia). BM Nair KJ Cheung Jr A Griffith JL Burns, J Clin Invest 2004 113 3 464 473 14755343
28. Conservation of a novel protein associated with an antibiotic efflux operon in Burkholderia cenocepacia. BM Nair LA Joachimiak S Chattopadhyay I Montano JL Burns, FEMS Microbiol Lett 2005 245 2 337 344 10.1016/j.femsle.2005. 03.027 15837391
29. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. JR Govan PH Brown J Maddison CJ Doherty JW Nelson M Dodd AP Greening AK Webb, Lancet 1993 342 8862 15 19 10.1016/0140-6736(93)91881-L 7686239
30. Efflux pump genes of the resistance-nodulation-division family in Burkholderia cenocepacia genome. P Guglierame MR Pasca E De Rossi S Buroni P Arrigo G Manina G Riccardi, BMC Microbiol 2006 6 66 10.1186/1471-2180-6-66 16857052
31. The genome of Burkholderia cenocepacia J an epidemic pathogen of cystic fibrosis patients. MT Holden HM Seth-Smith LC Crossman M Sebaihia SD Bentley AM Cerdẽo-Trraga NR Thomson N Bason MA Quail S Sharp I Cherevach C Churcher I Goodhead H Hauser N Holroyd K Mungall P Scott D Walker B White H Rose P Iversen D Mil-Homens EP Rocha AM Fialho A Baldwin C Dowson BG Barrell JR Govan P Vandamme CA Hart E Mahenthiralingam J Parkhill, J Bacteriol 2315 191 1 261 277 10.1128/JB.01230-08
32. A system for the construction of targeted unmarked gene deletions in the genus Burkholderia. RS Flannagan T Linn MA Valvano, Environ Microbiol 2008 10 6 1652 1660 10.1111/j.1462-2920.2008.01576.x 18341581
33. Efflux- mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei. RA Moore D DeShazer S Reckseidler A Weissman DE Woods, Antimicrob Agents Chemother 1999 43 3 465 470 10049252
34. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. O Lomovskaya MS Warren A Lee J Galazzo R Fronko M Lee J Blais D Cho S Chamberland T Renau R Leger S Hecker W Watkins K Hoshino H Ishida VJ Lee, Antimicrob Agents Chemother 2001 45 1 105 116 10.1128/AAC.45.1.105-116.2001 11120952
35. A multidrug efflux pump inhibitor reduces fluoroquinolone resistance in Pseudomonas aeruginosa isolates. AY Coban B Ekinci B Durupinar, Chemotherapy 2004 50 1 22 26 10.1159/000077280 15084801
36. Multidrug-resistance efflux pumps - not just for resistance. LJ Piddock, Nat Rev Microbiol 2006 4 8 629 636 10.1038/nrmicro1464 16845433
37. Vibrio cholerae RND family efflux systems are required for antimicrobial resistance, optimal virulence factor production, and colonization of the infant mouse small intestine. XR Bina D Provenzano N Nguyen JE Bina, Infect Immun 2008 76 8 3595 3605 10.1128/IAI.01620-07 18490456
38. The CepIR quorum-sensing system contributes to the virulence of Burkholderia cenocepacia respiratory infections. PA Sokol U Sajjan MB Visser S Gingues J Forstner C Kooi, Microbiology 2003 149 3649 3658 10.1099/mic.0.26540-0 14663096
39. Molecular cloning: a laboratory manual. J Sambrook DW Russell, Cold Spring Harbor Laboratory Press. Cold Spring Harbor, NY 2001
40. A plasmid which can be transferred between Escherichia coli and Pasteurella haemolytica by electroporation and conjugation. FF Craig JG Coote R Parton JH Freer NJ Gilmour, J Gen Microbiol 1989 135 11 2885 2890 2693589
41. Quorum sensing and Chromobacterium violaceum: exploitation of violacein production and inhibition for the detection of N-acylhomoserine lactones. KH McClean MK Winson L Fish A Taylor SR Chhabra M Camara M Daykin JH Lamb S Swift BW Bycroft GS Stewart P Williams, Microbiology 1997 143 Pt 12 3703 3711 10.1099/00221287-143-12-3703 9421896
42. Quorum-sensing system and stationary-phase sigma factor (rpoS) of the onion pathogen Burkholderia cepacia genomovar I type strain, ATCC 25416. C Aguilar I Bertani V Venturi, Appl Environ Microbiol 2003 69 3 1739 1747 10.1128/AEM.69.3.1739-1747.2003 12620866
43. A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR. VL Miller JJ Mekalanos, J Bacteriol 1988 170 6 2575 2583 2836362
44. Replication of an origin-containing derivative of plasmid RK2 dependent on a plasmid function provided in trans. DH Figurski DR Helinski, Proc Natl Acad Sci U S A 1979 76 4 1648 1652 10.1073/pnas.76.4.1648 377280